Company intelligence / Profile preview
Chongqing Jiachen Biotechnology Ltd.
- Ownership
- Private
- Development stage
- Phase 2
Overview
Chongqing Jiachen Biotechnology has developed a mimogen-based therapeutic hepatitis B vaccine that has completed Phase II clinical trials in China. The company operates a large GMP-certified facility and manages over 30 drug products marketed domestically. It is also active in contract research/clinical trial management using modern EDC systems.
- Therapeutic areas
- Infectious Diseases
- Modalities
- Therapeutic vaccinesLikely small molecules and biologics based on manufacturing scope
- Industry
- Biotech
Drug pipeline
1 assetPartnerships
Beyond the preview
Go deeper on Chongqing Jiachen Biotechnology Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Chongqing Jiachen Biotechnology Ltd..